Chemistfrog
Chemistfrog
Send Message
Chemistfrog
Stop FollowingChemistfrog
View Chemistfrog's StockTalks BY TICKER:
A,
AAPL,
ACRX,
AFFY,
ALXA,
APPA.OB,
APPY,
BIG,
BIOD,
BPAX,
CASH,
CE,
CHTP,
CLSN,
CLVLY.PK,
COO,
CRIS,
CRMD,
CTSO.OB,
CWTR,
DARA,
DCTH,
DD,
DSCO,
EPP,
EXEL,
GDX,
GDXJ,
GLD,
HNAB,
II,
III,
INO,
JAZZ,
NMTI.PK,
PAY,
PIII,
PPA,
PPHM,
PPS,
RAMO.PK,
SNSS,
SUPN,
SYN,
TLB,
TROV,
TSTRQ.PK,
USLV,
VVUS,
YMI,
ZLCS
-
Chemistfrog
Been buying safer stocks as of late. Work is too busy to babysit volatile pennies except for very small positions. - View all 5 replies
-
Chemistfrog: Wow.. Good luck and be careful sir. Sell some on the way up to secure gains in my opinion.. Best of luck ahead! Vacation here I come! :) -
joe kelly: Success to you as well. Your research has been a great tool.
-
Chemistfrog
Watching metals #silver & #gold closely. Specifically trading $GDXJ, $GDX and $USLV. #oversold? - View all 0 replies
-
Chemistfrog
Loving how biotechs have been performing! However, be careful. If market tops, the big runners drop hardest... - View all 0 replies
-
Chemistfrog
$BIOD should continue garnering interest up to the P2 data release. Strong move in the last week! - View all 0 replies
-
Chemistfrog
$GLD I'm still bullish here! Will sell to reduce at $143 and $149, while holding rest w/trailing stop limits.. - View all 3 replies
-
Chemistfrog: LOL! How did NUGT go? Sold my $GLD at 142 when it appeared to be struggling and chart was looking scary... Considering a $JJC entry... -
Chemistfrog: Considering a 50/50 position mix in $GDX and $GDXJ, or adding $GLD back into the mix as well. Any opinions?
-
Chemistfrog
$SUPN I believe entry down here is wise. Q1 financials could really give the company momo.. Final approval for Trokendi in June/July - View all 2 replies
-
joe kelly: You have any opinion on cytk? Keeps coming up on my radar along with supn. -
Chemistfrog: $CYTK chart is in breakout mode. Many catalysts ahead for 13. Watch earnings release for phase IIb update.. I like the company. Good future.
-
Chemistfrog
$INO traded down due to poor data from collaborator using their own DNA. Updates on the company using their own DNA could really push it up - View all 0 replies
-
Chemistfrog
$APPY sold off a bit last week and recovered Friday. I sold 1/2 into strength and am holding remainder.. - View all 0 replies
-
Chemistfrog
$CTSO is an exciting small company. Cytosorb is approved in Europe. Any IND filings for US clinicals would be huge.. - View all 0 replies
-
Chemistfrog
$AAPL is another one of those that I believe has been bashed down to current levels. I believe it wise to start accumulating here & lower.. - View all 0 replies
-
Chemistfrog
$TROV sold off last week. I accumulated a bit more as I can't believe it is down here. Looking for company updates.. - View all 0 replies
-
Chemistfrog
$SNRE still illiquid, but I believe it is HIGHLY UNDERVALUED. I have a small position but will add on any + clinical updates. - View all 0 replies
-
Chemistfrog
$BIOD looking strong. I will continue to accumulate here, but would LOVE to see $2.50 before run up to September data release. - View all 0 replies
-
Chemistfrog
$PAY I cannot see this dropping from these levels. watching to see if immediate inverse head-and-shoulders, bleed down or gradual recovery. - View all 0 replies
-
Chemistfrog
$ACRX looks to be consolidating for the next leg up. Before or after 1Q data release? $DARA with many imminent catalysts - View all 0 replies
-
Chemistfrog
EXEL should start getting a lot of serious attention going into 11/29 PDUFA cabozantinib. Priority review.. $EXEL - View all 0 replies
-
Chemistfrog
$DCTH trading near its all-time low despite earnings and company update on August 7th and NDA re-filing in August. - View all 1 replies
-
nsahbti: Company updates usually keep stocks level until the news is out. you know, making sure there are no surprises. Just buy more if you think.
